Philadelphia, Pennsylvania Clinical Trials

A listing of Philadelphia, Pennsylvania clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

positron emission tomography
flortaucipir
mini-mental state examination
florbetapir
alzheimer's disease
University of Pennsylvania Heath System
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
PCSK9i in AAA12

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test2a
 (5.1 away) Contact site
  • 0 views
  • 21 Nov, 2024
  • 1 location
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia
progranulin
pick's disease
dementia
University of Pennsylvania
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Evaluate the safety and tolerability of AMG 509 in adult subjects and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).

neutrophil count
antiandrogen therapy
serum testosterone
orchiectomy
metastasis
Research Site
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Niraparib/TTFields in GBM

Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM).

karnofsky performance status
MRI
recurrent glioblastoma
tumor treating fields therapy
glioblastoma
Hospital of the University of Pennsylvania
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
ELUCIDATE: Enabling LUng Cancer IDentification Using folATE Receptor Targeting

This is a phase 3, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/PET/MRI or other imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary …

lung cancer
wedge resection
pulmonary resection
folic acid
thoracic surgery
University of Pennsylvania
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
Accelerometer Sensing for Micra AV Study

The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.

atrioventricular block
Thomas Jefferson University
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

Prospective, multi-center, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Complex Abdominal Aortic Aneurysms.

Cooper University Hospital
 (4.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors

This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.

health screening
solid tumor
cancer
stage iv breast cancer
human chorionic gonadotropin
Sidney Kimmel Cancer Center
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

antiretroviral therapy
neutrophil count
oxaliplatin
hiv test
metastasis
Lankenau Medical Center
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations